Pliant Total Current Liabilities vs Property Plant Equipment Analysis
PLRX Stock | USD 12.13 0.04 0.33% |
Pliant TherapeuticsInc financial indicator trend analysis is much more than just breaking down Pliant TherapeuticsInc prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Pliant TherapeuticsInc is a good investment. Please check the relationship between Pliant TherapeuticsInc Total Current Liabilities and its Property Plant Equipment accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pliant TherapeuticsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Pliant Stock please use our How to Invest in Pliant TherapeuticsInc guide.
Total Current Liabilities vs Property Plant Equipment
Total Current Liabilities vs Property Plant Equipment Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Pliant TherapeuticsInc Total Current Liabilities account and Property Plant Equipment. At this time, the significance of the direction appears to have strong relationship.
The correlation between Pliant TherapeuticsInc's Total Current Liabilities and Property Plant Equipment is 0.66. Overlapping area represents the amount of variation of Total Current Liabilities that can explain the historical movement of Property Plant Equipment in the same time period over historical financial statements of Pliant TherapeuticsInc, assuming nothing else is changed. The correlation between historical values of Pliant TherapeuticsInc's Total Current Liabilities and Property Plant Equipment is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Liabilities of Pliant TherapeuticsInc are associated (or correlated) with its Property Plant Equipment. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Property Plant Equipment has no effect on the direction of Total Current Liabilities i.e., Pliant TherapeuticsInc's Total Current Liabilities and Property Plant Equipment go up and down completely randomly.
Correlation Coefficient | 0.66 |
Relationship Direction | Positive |
Relationship Strength | Significant |
Total Current Liabilities
Total Current Liabilities is an item on Pliant TherapeuticsInc balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Pliant TherapeuticsInc are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Property Plant Equipment
Most indicators from Pliant TherapeuticsInc's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Pliant TherapeuticsInc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pliant TherapeuticsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Pliant Stock please use our How to Invest in Pliant TherapeuticsInc guide.Sales General And Administrative To Revenue is likely to rise to 38.50 in 2024, whereas Selling General Administrative is likely to drop slightly above 29.4 M in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Interest Income | 272K | 4.7M | 20.5M | 21.5M | Net Interest Income | 272K | 3.9M | 19.2M | 20.2M |
Pliant TherapeuticsInc fundamental ratios Correlations
Click cells to compare fundamentals
Pliant TherapeuticsInc Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Pliant TherapeuticsInc fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 119.1M | 295.5M | 221.2M | 350.6M | 512.2M | 537.8M | |
Total Current Liabilities | 8.2M | 11.6M | 16.8M | 23.9M | 28.5M | 15.3M | |
Total Stockholder Equity | (435K) | 283.1M | 199.1M | 313.3M | 473.6M | 497.3M | |
Net Tangible Assets | (76.3M) | 283.1M | 199.1M | 313.3M | 360.3M | 378.4M | |
Retained Earnings | (76.3M) | (117.8M) | (215.1M) | (338.4M) | (499.7M) | (474.8M) | |
Accounts Payable | 1.3M | 2.0M | 3.0M | 1.6M | 4.5M | 2.6M | |
Cash | 85.8M | 50.9M | 51.7M | 33.7M | 63.2M | 55.1M | |
Cash And Short Term Investments | 102.8M | 276.9M | 200.6M | 331.2M | 494.2M | 519.0M | |
Net Receivables | 7.4M | 9.4M | 2.1M | 2.1M | 3.0M | 3.9M | |
Total Liab | 119.5M | 12.5M | 22.2M | 37.3M | 38.6M | 34.4M | |
Total Current Assets | 111.9M | 290.8M | 209.4M | 340.3M | 505.5M | 530.8M | |
Property Plant Equipment | 4.1M | 4.3M | 10.9M | 4.5M | 5.2M | 5.5M | |
Short Long Term Debt Total | 444K | 283K | 7.2M | 15.8M | 11.4M | 6.5M | |
Other Current Liab | 6.9M | 9.6M | 12.0M | 19.9M | 22.7M | 13.5M | |
Property Plant And Equipment Net | 4.1M | 4.3M | 10.9M | 9.9M | 4.8M | 7.0M | |
Net Debt | (85.4M) | (50.6M) | (44.5M) | (17.9M) | (51.9M) | (54.5M) | |
Non Current Assets Total | 7.2M | 4.8M | 11.8M | 10.3M | 6.7M | 8.3M | |
Non Currrent Assets Other | 3.1M | 451K | 838K | 394K | 392.0K | 759.5K | |
Other Assets | 3.1M | 451K | 838K | 394K | 1.0 | 0.95 | |
Common Stock Shares Outstanding | 35.6M | 35.6M | 35.8M | 42.0M | 58.7M | 41.1M | |
Short Term Investments | 17.0M | 226.0M | 148.9M | 297.5M | 431.0M | 452.6M | |
Liabilities And Stockholders Equity | 119.1M | 295.5M | 221.2M | 350.6M | 512.2M | 286.9M | |
Non Current Liabilities Total | 111.3M | 866K | 5.3M | 13.4M | 10.1M | 9.6M | |
Capital Lease Obligations | 444K | 283K | 7.2M | 5.9M | 1.3M | 1.3M | |
Other Current Assets | 1.7M | 4.5M | 6.8M | 7.1M | 8.3M | 5.2M | |
Other Stockholder Equity | 2.2M | 105.4M | 414.3M | 653.7M | 973.0M | 1.0B | |
Net Invested Capital | (76.3M) | 283.1M | 199.1M | 323.3M | 483.6M | 507.8M | |
Accumulated Other Comprehensive Income | (1K) | (32K) | (201K) | (2.0M) | 345K | 362.3K | |
Non Current Liabilities Other | 10K | 2K | 5.3M | 3.4M | 3.9M | 4.1M | |
Net Working Capital | 103.7M | 279.2M | 192.6M | 316.4M | 477.0M | 261.3M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Pliant TherapeuticsInc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Pliant TherapeuticsInc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Pliant Therapeuticsinc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Pliant Therapeuticsinc Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pliant TherapeuticsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Pliant Stock please use our How to Invest in Pliant TherapeuticsInc guide.You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Complementary Tools for Pliant Stock analysis
When running Pliant TherapeuticsInc's price analysis, check to measure Pliant TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pliant TherapeuticsInc is operating at the current time. Most of Pliant TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Pliant TherapeuticsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pliant TherapeuticsInc's price. Additionally, you may evaluate how the addition of Pliant TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |
Is Pliant TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pliant TherapeuticsInc. If investors know Pliant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pliant TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.86) | Revenue Per Share 0.004 | Quarterly Revenue Growth (1.00) | Return On Assets (0.22) | Return On Equity (0.34) |
The market value of Pliant TherapeuticsInc is measured differently than its book value, which is the value of Pliant that is recorded on the company's balance sheet. Investors also form their own opinion of Pliant TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Pliant TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pliant TherapeuticsInc's market value can be influenced by many factors that don't directly affect Pliant TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pliant TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pliant TherapeuticsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pliant TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.